Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1598 | Thyroid (non-cancer) | ICEECE2012

The influence of recombinant human thyroid stimulating hormone (rhTSH) on the efficacy of radioiodine therapy in patients with toxic nodular goitre with low RAIU

Abdelrazek S. , Rogowski F. , Szumowski P. , Daniluk M. , Winska M. , Szorc M.

The aim of our study was to evaluate the influence of rhTSH on the efficacy of radioiodine therapy (RIT) in patients with toxic nodular goitre(TNG) with low RAIU. Materials and methods: The study was performed on 30 patients with TNG (22 female and 8 male aged 45–78years) referred for 131I therapy. All patients had low RAIU (16–18%) 24 hours after a diagnostic dose of I-131 (4 MBq). All the patients received a single intramuscular dose of 0.05 mg rhTSH (thyrogen). 24...